Found 72 matching trials
PET/MRI to Stage Prostate Cancer Patients PHASE2 The main goal of this phase II clinical trial is to define a novel approach...
Show More Location
IRCCS Ospedale San Raffaele
Learn More & Join Trial
NEPC Study: An Exploratory Safety and Efficacy Study With PSMA, SSTR2 and GRPR Targeted Radioligand Therapy in Metastatic Neuroendocrine Prostate Cancer. PHASE1 The purpose of this study is to evaluate the change in the expression of tr...
Show More Status
Active Not Recruiting
Location
Nebraska Cancer Specialists
Learn More & Join Trial
Phase 2 Randomized Trial of Flexible Dosing Schedule of 177Lu-PSMA-617 for the Treatment of Metastatic Castration-Resistant Prostate Cancer (FLEX-MRT) PHASE2 In advanced metastatic castration resistant prostate cancer (mCRPC) progres...
Show More Location
UCLA / Jonsson Comprehensive Cancer Center
Learn More & Join Trial
Study of 177Lu-PSMA-617 In Metastatic Castrate-Resistant Prostate Cancer in Japan PHASE2 The purpose of this study is to assess the efficacy, tolerability, safety, ...
Show More Location
Novartis Investigative Site
Learn More & Join Trial
PET/MRI in Patients With Suspected Prostate Cancer PHASE3 This diagnostic clinical trial will be conducted according to a randomized,...
Show More Location
Department of Biomedical Imaging and Image-guided Therapy
Learn More & Join Trial
Study to Assess [177Lu]Lu-PSMA-R2 (AAA602) and [225Ac]Ac-PSMA-R2 (AAA802) in Participants With PSMA-positive HRLPC PHASE1 The purpose of this trial is to learn more about the effects of AAA602 and ...
Show More Location
Multiple Locations
Learn More & Join Trial
68Ga-PSMA-11 PET/CT Screening Prior to 177Lu-PSMA-617 Therapy for Patients With Metastatic Castrate Resistant Prostate Cancer PHASE3 This phase III study provides access to 68Ga-PSMA-11 positron emission tomo...
Show More Location
Mayo Clinic in Rochester
Learn More & Join Trial
Novel Ga68-PSMA PET/CT-tracer to Differentiate Between Radiation Necrosis and Tumor Progression in Brain Metastases NA This study aims to evaluate the diagnostic potential of 68-Gallium PSMA-PET...
Show More Location
Netherlands Cancer Institute - Antoni van Leeuwenhoek
Learn More & Join Trial
Schedule De-Escalation of 177Lu-PSMA-617 for the Treatment of Metastatic Castrate Resistant Prostate Cancer PHASE2 This phase II trial studies how to improve the usage of Lu 177 vipivotide t...
Show More Location
Mayo Clinic in Rochester
Learn More & Join Trial
Gallium Ga 68-labeled PSMA-11 PET/CT in Detecting Recurrent Prostate Cancer in Patients After Initial Therapy PHASE3 This clinical trial studies how well gallium Ga 68-labeled prostate-specifi...
Show More Location
UCLA / Jonsson Comprehensive Cancer Center
Learn More & Join Trial